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Pre- exposure prophylaxis (PrEP) is a biomedical intervention that was approved by the Federal 
Drug Administration (FDA) in 2012 to reduce the chances of acquiring HIV (human 
immunodeficiency virus) by 90% or more. Numerous studies have been conducted worldwide 
analyzing different risk populations and showing the efficacy of PrEP by reducing transmission 
of HIV. Currently, the state of Michigan has very little evidence on who is taking PrEP, which 
facilities are prescribing or referring PrEP, or what PrEP activities are taking place in a clinical 
setting. Local health departments (LHDs) are key players in screening individuals who are at risk 
for getting STDs, which serve as a population of those who could also get infected with HIV.     
  
Methods 
In 2017, the Michigan Department of Health and Human Services (MDHHS) developed a survey 
to assess LHDs capacity, processes, and technical assistance regarding PrEP. Prior to this survey 
there has been one other survey about PrEP but was only distributed to private physicians in 
Michigan. The current survey was sent to 45 LHDs, with responses from medical directors, 
health officers, and STD clinic management. The survey was designed to assess three 
components for each LHDs: current PrEP activities, strengths and weakness of the activities, and 
potential resources or tools that could aid clinics in future PrEP implementation.        
 
Results 
The results revealed that there were 59 respondents and of the 45 LHDs in the state, 42 (93%) 
provided responses. According to the three groups of respondents, 12% of clinics were 
prescribing PrEP, 52% were referring PrEP, and 37% were not doing any activities around PrEP. 
Clinics who are currently prescribing PrEP want to continue their PrEP activities and monitor 
PrEP uptake. However, 64% of clinics indicated they were undecided or not likely to implement 
PrEP in the future. All clinics expressed interest in receiving more guidance from the state health 
department and an increase of education and resources for staff and patients.       
 
Conclusion 
Considering this was a baseline survey, the response rate was quite high for LHDs throughout 
Michigan. The survey indicated what PrEP activities LHDs were engaging in and what they 
would like to do in the future. About half of the respondents stated they are not doing any 
activities around PrEP, which can call for more action in those clinics. However, all respondents 
expressed interest in receiving more information and resources on how to expand PrEP activities 
in their clinic.  
  





As of 2016, The Center for Disease Control and Prevention (CDC) (2017-a), classifies 
the Human Immunodeficiency Virus (HIV) as an infection that kills the body’s CD4 cells (T 
cells) and destroys the immune system.  HIV is commonly known to spread through sharing 
needles or syringes, sexual contact (anal, oral, or vaginal), blood transfusions, or perinatal 
transmission – as in from an infected mother to a child (CDC, 2017-c). There is no cure for 
HIV/AIDS but medications like anti-retroviral therapy (ART) can help slow the progression by 
reducing the replication process of HIV. If an individual suspects they may have acquired HIV, 
rapid tests can be used to determine preliminary results for HIV. If a test is positive then the 
individual will follow-up with additional blood work to identify the viral load and CD4 count. 
The CD4 and viral load helps establish the severity of the disease. Thus, a viral load is the 
amount of copies a person has of HIV in their system (AIDSMap, 2017). A CD4 count is the 
number of T cells in the body that protect from infection. A viral load of 100,000 copies per mL 
is considered having a lot of HIV in the body. Also, a CD4 count less than 200 means there are 
very few T cells helping fight the high amount of HIV in the body (AIDSMap, 2017). The viral 
load and CD4 counts pinpoint the stage of HIV and the prognosis of the disease. In a person 
living with HIV, continuous blood work is required to ensure the disease is being monitored and 
does not progress to the acquired immunodeficiency syndrome (AIDS), which is the third stage 
of HIV. 
There are three distinct stages of HIV, with the first being known as the acute HIV 
infection stage. This stage usually occurs 2 to 4 weeks after contact with an HIV-infected person. 
The CDC (2017-a) has indicated that some individuals will experience signs and symptoms that 
are similar to the flu in response to the infection. The second stage of infection, clinical latency, 




is referred to as the stage that can be asymptomatic. The HIV virus reproduces very slowly but 
can also be very infectious at this stage. Those who are taking ART for HIV can stay in this stage 
for a long period of time and reduce the chances of transmitting HIV to another individual, if 
medication is taken correctly and viral loads are low (CDC, 2017-a). The last stage of HIV is 
when an individual progresses to AIDS. This means that their immune system has been damaged 
so badly that they are at a very high risk for opportunistic infections. If individuals do not take 
ART as prescribed they can increase their chances of death along with a high viral load causing 
HIV to be transmitted very easily to their partners (CDC, 2017-a). With the proper use of ART, 
HIV can be a very manageable disease. Those who are living with HIV can have low or 
undetectable viral loads, reduce transmission to others, and live a life free of AIDS.            
The first case of AIDS was reported in Los Angeles on June 5th, 1981. Most people, 
including scientists, believed it was only being transmitted by gay men, which is why it was 
initially referred to as “The Gay Man’s Disease”. However, a year later, it was then thought that 
AIDS was being transmitted through blood products and pregnancies. According to the CDC’s 
HIV/AIDS timeline, female partners of males and needle sharing partners reportedly began 
acquiring AIDS between 1983 and 1984 (National Prevention Information Network [NPIN], 
2017). At the time, doctors and scientists could not understand the seriousness of the quickly 
progressing disease. In 1986, the CDC announced that they were certain HIV was not transmitted 
through casual contact, food, water, air or environmental surfaces. Although individuals were 
being educated about AIDS, over a half million (683,000) people were already living with HIV 
by the end of the 1980s. It was not until around 1995 that the CDC established guidelines on 
prevention of HIV transmission and opportunistic infections (NPIN, 2017). Toward the end of 
the 1990s, while mortality was finally declining, a guide was developed on the use of medication 




for persons living with HIV. Before entering the 2000s, the number of persons living with HIV 
was close to a million. During the millennial years, congress took a big step in creating funding 
for prevention and for those who were already living with HIV, such as the Global AIDS and TB 
Relief Act, the President’s Emergency Plan for AIDS Relief Act, and Act against AIDS (NIPN, 
2017). In 2008, the CDC estimated that over half a million people had died from AIDS and 
predicted there would be 56,300 new infections a year. From 2011 on, the release of a new 
framework to focus on HIV prevention efforts was established. HIV treatment, was shown to 
reduce transmission by 96% (if undetectable viral loads are present) and the first evidence-based 
study of PrEP was in the processes of being approved by the FDA (NIPN, 2017). After 
continuous research, education, and prevention efforts over the past decade, significant progress 
has been made with reducing HIV rates, although an epidemic still remains in some populations.  
According to the CDC (2017-c), 1 in 2 gay or bisexual Black men will acquire HIV and 1 
in 6 gay or bisexual men will be diagnosed with HIV in the years to come if trends remain the 
same. As of 2014, there were 37,600 new HIV infections and an estimated 1.1 million people are 
currently living with HIV in the United States. However, 1 in 7 individuals in the U.S. do not 
know that they are infected with HIV. As of recent, the CDC (2017-c) stated, all new HIV 
infections are 70% male-to-male sexual contact, 23% heterosexual contact, and 7% include both 
injection drug users (IDU) and men who have sex with other men (MSM). Also, in 2015 Blacks 
were disproportionately impacted by HIV, making up 45% of all new HIV infections. 
Specifically, Black males aged 13-24 years old is the population impacted most significantly by 
HIV. Although, the CDC (2017-c) showed, Blacks only account for 16% of the population, they 
comprise 22% of new HIV infections. Following Blacks, Whites represent 27% of those newly 
diagnosed with HIV and Hispanics 24% (CDC, 2017-c). Reviewing the most highly-impacted 




subpopulations from 2015; 10,315 were Black MSM, 7,570 White MSM, 4,142 Black 
heterosexual women, and 1,926 Black heterosexual men (CDC, 2017-c). Moreover, sexually 
transmitted diseases (STDs) are an indicator of risky behaviors that can transmit HIV as well as 
other STDs. These rates suggest HIV is a continuing public health problem within the U.S. 
Michigan is closely monitoring the same trends for those age groups with new HIV 
infections. Particularly, the Michigan Department of Health and Human Services (MDHHS) 
division of STD supports all LHDs and other community partners to assure services are 
accessible to those at highest risk – despite ability to pay. The STD program goals are to report 
cases in a timely manner, review the screening and treatment services, and investigate cases to 
reduce and intervene with the spread of disease. New HIV infections have slowly increased 
throughout the state of Michigan from 653 in 2014 to 735 cases in 2016 with rising rates 
prominent in MSM, who represent 22% of new infections (MDHHS, 2015-b). Additionally, from 
2009 to 2013, MSM accounted for 56% of new HIV cases, with Blacks comprising 57% of those 
cases (MDHHS, 2015-b). Likewise, MDHHS (2015-a) indicated on their HIV factsheet that in 
2015 young teenagers (13-24) who identify as MSM made up 600 of the new HIV cases – 486 of 
which were Black. Thus, the public health focus nationally and statewide is developing 
interventions to reduce the disproportionately high rates of HIV infection in young MSM aged 
13-24 years old. Due to the staggering rates of HIV, there is a calling for the need of PrEP 
implementation in clinics across the country.            
Literature Review 
Although there is no cure for HIV/AIDS, there is a biomedical intervention that has been 
developed to reduce the transmission of HIV. Pre-exposure prophylaxis (PrEP) is a daily dosing 
of tenofovir and emtricitabine (Truvada ©) used for preventing HIV. Several studies conducted 




with different risk populations have demonstrated the efficacy of PrEP. One of the most popular 
studies is the Pre-exposure Prophylaxis Initiative (iPrEX), which was conducted in Peru, 
Ecuador, Brazil, Thailand, South Africa, and the United States. Grant et al. (2010) recruited 
2,499 men and transgender women who were HIV-negative, 18 years or older, and given 
antiretroviral drugs (Truvada) or a placebo for the duration of three years to participate in the 
study. In addition to the intervention, all participants were given standard practices of care, 
including risk-reduction counseling, and education on STDs. The participants were asked to 
return for follow-up appointments at 4, 8, 12, 16, 24 weeks, and then every 12 weeks thereafter 
(Grant et al., 2010). During those visits, an HIV test was administered and the self-reported 
number of pills was measured to determine adherence to medication. At the end of the study, 36 
individuals from the intervention group and 64 from the placebo group were found to be HIV 
positive. Interestingly, the report of high-risk behavior decreased throughout the study (Grant et 
al, 2010). Overall, with the combination of risk-reduction counseling, education, routine testing, 
and the daily dose of Truvada resulted in a reduction of HIV incidence by 44%. 
Another popular study that had positive outcomes for HIV prevention was the 
Antiretroviral Pre- Exposure Prophylaxis for Heterosexual HIV Transmission study (TDF2; 
Thigpen et al., 2012). In 2008, Botswana had the second highest prevalence of HIV in the world, 
with 30-44 year-olds representing 40% of their infected  population (Thigpen et al., 2012). The 
TDF2 study proceeded the TDF1 study trail. The latter evaluated the safety and efficacy of PrEP, 
whereas participants were given a daily dose of tenofovir disoproxil furmarate and emtricitabine 
(TDF-FTC) as the intervention in the former. The TDF2 study was a double-blind, placebo-
controlled clinical trial focusing on sexually active men and women aged 18-39 years old. To be 
eligible for the study, participants had to engage in routine testing for HIV, Hepatitis B, and 




other STDs (Thigpen et al., 2012). During the recruitment process, most participants indicated 
that they had only one sexual partner in the previous month. Of the 2,533 individuals screened at 
baseline, less than half (1,219) of the participants were eligible for the study. Between the 
intervention and placebo group, medication adherence was measured by pill count. Comparably, 
Thigpen et al. (2012) noted that the TDF-FTC group adhered to the medication 84% of the time 
and the placebo group 83.7%. Additionally, approximately 80% of individuals reportedly used 
condoms during sexual encounters for both groups. None of the participants reported engaging in 
anal intercourse. At the end of the study, 36 participants became infected with HIV: 10 in the 
TDF-FTC group and 26 in the placebo group (Thigpen et al., 2012). The overall efficacy of the 
TDF-FTC daily pill decreased the rate of HIV infection by 62% – which translates to 1.3 cases 
per 100 persons in the intervention group and 3.1 cases per 100 persons in the placebo group. 
From the results, Thigpen and colleagues (2012) suggest that sexually active individuals who 
occasionally used condoms were twice as likely to acquire HIV as those who were using PrEP.  
Similarly, a study conducted in Kenya and Uganda, Antiretroviral Prophylaxis for HIV 
Prevention in Heterosexual Men and Women (also known as the Partners PrEP study), engaged 
in a randomized trial for HIV-discordant heterosexual couples. HIV-discordant couples means 
that one partner is living with HIV and the other is not. Baeten et al. (2012) indicated three study 
groups where one was assigned a daily pill with just a TDF dosing, the second received a 
combination of TDF and FTC, and the third was the placebo group. For 36 months, 4,747 
individuals were followed, including 1,574 participants in the TDF group, 1,579 in the TDF-FTC 
group, and 1,584 in the placebo group (Baeten et al., 2012). The partner who was not infected 
with HIV, 62% of them being males, was offered an HIV test, counseling service, couples risk-
reduction, treatment for STDs, and free condoms at the time of screening. Following baseline 




data collection, participants were re-evaluated every month by receiving a new HIV test and 
prescription based on their study group, if they tested negative for HIV. During the study period, 
the retention rate for completing at least one HIV test was 96% or greater and a 98% return rate 
for the monthly pill count (Baeten et al., 2012). At the end of the study, 82 individuals became 
HIV positive: 17 participants in the TDF group, 13 in the TDF-FTC group, and 52 in the placebo 
group. At the end of the study, Baeten et al. (2012) had shown data to have a cumulative 
reduction rate of HIV by 67% using the TDF drug and 75% with the combination of TDF-FTC. 
From the results, researchers can infer that taking the combination dose of TDF and FTC can 
increase the efficacy of reducing HIV infection compared to just taking one dose, but even if a 
single dose was used it would still reduce the chances of acquiring HIV.             
The last notable PrEP trial study was conducted in Southeast Asia. From June 2005 to 
July 2010, Choopanya et al. (2013) analyzed a slightly different population than the previously 
stated studies. The Antiretroviral prophylaxis for HIV infection in injecting drug users (IDU) in 
Bangkok, Thailand (the Bangkok Tenofovir study) sought to determine if IDU could reduce rates 
of HIV by harnessing the drug tenofovir (Choopanya et al., 2013). A double- blind, randomized 
control trail involved 17 drug-treatment clinics who recruited 2,413 IDUs that were HIV 
negative and between the ages 20-60 years old. Throughout the study, Choopanya et al. (2013) 
provided information that every 28 days participants were assessed based on their adherence, 
HIV test, and risk-reduction counseling. Study staff assigned participants to a drug based on a 
random number not known to the study investigator or participants. To ensure this was a double-
blind study, both the placebo and intervention drugs were similar in shape, color, and taste 
(Choopanya et al., 2013). The results of the study were significant with only 50 participants 
becoming infected with HIV, 17 in the TDF group and 33 in the placebo group. Overall, HIV 




incidence was reduced by 48.9% for IDU with higher efficacy in women and those 40 years or 
older (Choopanya et al., 2013).               
As stated from the four most popular studies in the United States, PrEP has significantly 
shown its efficacy of reducing the chance of acquiring HIV. Although PrEP was approved by the 
Federal Drug Administration (FDA) in 2012, very few studies have investigated PrEP 
implementation in local health departments (LHDs). However, in July 2015 the National 
Association of County and City Health Officials (NACCHO) developed a survey to establish a 
better understanding of PrEP in clinical settings across the nation. The survey was extensive in 
questions but assessed similar aspects to the MDHHS PrEP Survey. NACCHO’s main goal for 
the survey was to better understand the role of LHDs activities around implementation, needs, 
challenges, opportunities, and next steps. The survey invited 500 HIV/STD program managers 
throughout the country and were randomly selected based on HIV rates, region, and population 
size. Data was collected through a questionnaire powered by Qualtrics®, which had a two 
component instrument. 
The two components of the survey were LHDs who were engaged in PrEP 
implementation and the LHDs not engaged in PrEP implantation (Weiss, Smith, Newman, & 
Kitlas, 2015). From the results of the survey, there were a total of 284 responses, indicating a 
58% response rate. From the assessment, 38% of LHDs were engaged in some type of activity 
with PrEP, 52% of those were from the west region, and 67 % served large populations. After 
reviewing the responses from those who manage only STD clinics, 4% were prescribing PrEP 
and 57% were referring patients to other clinics for PrEP. However, all LHDs (including STD 
clinics), 75% were referring PrEP to high-risk individuals and 10% were delivering PrEP (Weiss 
et al., 2015). Of the LHDs engaged in PrEP, 50% were conducting community education and 




outreach, 29% identified providers and a referral list, 45% collaborated with providers to support 
PrEP delivery, 43% conducted healthcare provider outreach, 41% conducted training events for 
staff, 39% participated in PrEP workgroups, 13% monitored and evaluated PrEP, 8% 
participated in a pilot study, and 6% funded community-based organizations (Weiss et al., 2015). 
The survey then asked participants what their optimal role was for PrEP implementation. 
Responses were consistent with current PrEP activities, with 77% of LHDs expressing a desire to 
refer high-risk patients to PrEP and 33% wanting to deliver PrEP (Weiss, et al., 2015). The main 
challenges for LHDs implementing PrEP was limited staff capacity, concern about financial 
access to PrEP, lack of enough providers willing to provide PrEP, and lack of awareness and 
knowledge among staff. The latter two responses are particularly important because 77% 
expressed wanting to refer PrEP but could not due to a lack of education among staff within the 
LHDs. In regards to LHDs who responded to the question about the need for more information 
and resources, 51% expressed a desire to know more about cost and reimbursement for PrEP, 
49% reported a desire for educating healthcare providers about PrEP, 39% expressed interest in 
assistance with identifying providers for referrals, and 30% reported needing assistance with 
protocols for referring PrEP. Weiss et al., (2015), further cited that some resources LHDs 
thought would help with PrEP implementation include, education materials for providers, 
additional funding, protocols for referrals, and protocols for prescribing PrEP. 
Overall, 53% of those engaged in PrEP implementation plan to expand their activities, 
while 18% of those not engaged in PrEP activities anticipate they will expand their activities 
within the next four years. The efficacy of PrEP has been shown to be mostly successful along 
with surveys assessing PrEP implementation, Michigan’s next steps are to follow the same path. 
Michigan will apply PrEP interventions and activities in LHDs, especially for those who have 




high morbidity of STDs and HIV. Michigan’s LHD PrEP survey has questions and responses 
similar to the NACCHO survey.         
Public Health Significance / Community Significance 
Currently, the CDC does not require any state to report the number of individuals who 
have been referred to or are actively taking PrEP. As the NACCHO survey stated, a lot of areas 
are prescribing or referring PrEP, but they are only recording their data through their state 
surveillance systems or electronic medical record (EMR). Similarly, the MDHHS has little 
information on who is prescribing PrEP, who is taking PrEP, or what barriers community 
partners may encounter when attempting to increase PrEP services. Although a survey was 
created by MDHHS to assess knowledge and capacity around PrEP, it was directed toward 
private physicians. Thus, more information in this area should be obtained from the public 
sector. As a venue where hundreds of individuals seek health services daily, a similar survey was 
distributed to better understand what LHDs are doing regarding PrEP. The survey was designed 
to specifically determine the challenges, barriers, and future considerations LHDs have within 
their clinic and how MDHHS can help increase their capacity to implement PrEP. Additionally, 
the LHD PrEP survey was intended to assist the HIV and STD program in creating new 
interventions for clinics throughout Michigan. 
Interventions could include developing a new way to record individuals who might be 
prescribed PrEP in the surveillance system or develop protocols for clinics that need assistance 
implementing PrEP strategies. Most importantly, this assessment was intended to help create 
better outcomes for patients by finding barriers and reducing the gaps in care for those who are at 
a higher risk for acquiring HIV. For approximately two months, the current project evaluated 
current PrEP capacity, implementation plans, and technical assistance needs in LHDs. The 




subsequent goal is to increase PrEP knowledge and resources for LHDs, which will take action 
within the next year. Lastly, over the next five years, the long-term goal is to implement a PrEP 
intervention in at least three areas of high STD and HIV incidence.                        
Methods 
Sampling 
A non-random convenience sampling technique was used to recruit 45 LHDs in 
Michigan. This type of sampling method was the best option for this survey because it was easy 
to identify the target population (STD/HIV clinics), which was selected within the 45 LHDs. A 
pre-existing list of individuals from MDHHS was used to recruit participants so that they could 
be identified by their LHD. Identification of LHDs through convenience sampling assisted with 
feedback to MDHHS after finalizing the survey to help exclude participants, if necessary. This 
method offered the most efficient, accessible, and cost-effective route to collect the data. The 
groups who received an invitation to participate in the survey were medical directors, health 
officers, and STD program managers whom worked directly in the STD or HIV clinics. This 
type of selection was necessary for this specific survey because those individuals would be the 
most knowledgeable about their local STD/HIV program. 
Recruitment  
A cover letter describing what the survey was about and who to contact if there were 
questions or trouble accessing the survey online was emailed to the 45 LHDs. During the second 
week of the survey, a reminder was verbally relayed at the annual STD/HIV Conference where 
most eligible participants were present. On the day the survey was initially supposed to be 
closed, a reminder email was sent to participants notifying them that the survey has been 




extended for another week. At the beginning of the fourth week, the remaining LHDs who did 
not fill out a survey were directly contacted via telephone or email to complete the survey. This 
last step was done to guarantee all 45 LHDs would complete the survey. The survey was 
monitored on a weekly basis to ensure the sample was being collected and that there were no 
errors. Participants were not offered any incentives for completing the survey, nor did they face 
any penalties for choosing not to take the survey. By the close of the survey, a total of 42 of the 
45 LHDs responded.   
Procedures & Data Collection 
All study procedures were reviewed and approved by the University of Michigan – Flint 
Institutional Review Board (IRB). MDHHS did not require an application for IRB. The final 
report will be disseminated to each LHD for reflection and improvement of PrEP activities.        
Participants were asked to complete a self-administered, 20-25 item (depending on 
responses) survey via SurveyMonkey. Survey items were answered via yes/no, open-ended, and 
multiple choice responses. The survey was comprised of five sections: background on the clinic 
and PrEP, engagement in PrEP activities, PrEP capacity and implementation, next steps for PrEP 
implementation, and resources or tools for PrEP. PrEP capacity and engagement were assessed 
via participants’ responses to the question, “Do you offer any PrEP related services in your 
clinic?” Each response determined which corresponding group of questions the participant would 
answer. Responses included the following: we are prescribing PrEP, we are referring individuals 
to other clinics for PrEP, we don’t know much about PrEP and are not doing any activities 
around PrEP, we know about PrEP but are not doing any activities around PrEP, and we are 
interested in PrEP but do not know where to start. The latter three responses were grouped into 
one group, for analysis purposes. Participants were asked to determine to which group their 




clinic belonged. Following that selection, a skip pattern was presented based on the previous 
response. All surveys were anonymous with the exception of knowing which LHD was reporting 
their answers. This was mainly used to receive direct feedback from a certain clinic. After the 
survey ended, only the PI (Masters of Public Health student) gathered all responses and 
statistically analyzed the data. Descriptive statistics were applied using Microsoft Excel 
formulas. Open-ended data was added to the end of the results section to review personal 
comments from some LHDs for feedback to MDHHS.    
Statistical Analysis  
Participants were grouped by current PrEP activities pertaining to their clinic at the time 
of assessment. The response groups were mutually exclusive and three separate analyses were 
required to produce the correct output using Microsoft Excel. The PI analyzed the data from 
responses of each group by sorting through every question and then reviewing the responses to 
obtain a frequency for that particular group. Tables and figures with proportions were created for 
the three response groups using Microsoft Excel formulas for visual representation of data.  
Results 
From the surveys that were distributed, there was a total of 58 responses which included 
42 of the LHDs in Michigan. Some surveys had more than one response but it was intended to 
gain a variety of data from all levels of management. Of the 58 respondents, the most frequent 
profession that completed the survey was a registered nurse (67%), followed by nurse 
practitioners (12%), and less than 2% was either a social worker, physician, medical director, or 
other profession (see Graphic A1). Survey responses yielded three groups: 12% of LHDs that 




reported prescribing PrEP (Group 1), 52% that reported referring PrEP (Group 2), and 36% that 
reported not doing any activities around PrEP (Group 3; Graphic A2).  
 Background information on the clinic and PrEP activities were reported by all seven 
participants of the first survey response group (Table B1). Forty-three percent of the data from 
the clinics in the first group was completed by nurse practitioners. Each of the clinics in the first 
group indicated that at least a quarter of primary care, family planning, mental health services, 
medication adherence support, insurance navigation, transport assistance, and other was offered 
in their LHD. In addition, 86% of respondents had a nurse practitioner on-site at least four hours 
per week. Of the LHDs that were billing, 43%billed for HIV services, 86% for STD services, 
29% for hepatitis services, and 43% for family planning. Three clinics reported prescribing PrEP 
to 10-24 individuals in the past year. A majority of the clinics specified they were doing one of 
the following: taking a comprehensive sexual history (100%), determining if a patient is eligible 
for PrEP (100%), ensuring that front desk staff are aware that PrEP is offered and can triage 
patients accordingly (86%), ensuring that the clinic knows about the HIV consultation portal 
(86%), and ensuring that the clinic has protocols to link patients to support services (86%). 
The number one reason that clinics in group one started to prescribe PrEP was due to the 
patients increase interest, as reported by 71% of the group one respondents. In addition, 43% 
indicated that the increase of discussion at conferences and trainings influenced them to 
implement PrEP. Eighty-six percent reported that education and training about PrEP for staff is 
based on in person trainings with or without continuing education credits. An error in the survey 
prohibited insight regarding the challenges, strengths, or concerns for the first group. The user 
error was caused by a missed step in the survey development processes and a lack of testing 
before the survey was sent. Participants in response group one expressed that 86% would like to 




continue to support PrEP, 43% would like to do more community outreach in the future, and 
71% of participants would like to help other clinics. Over half (57%) would like to expand their 
activities by monitoring and evaluating PrEP. Following those who would like to monitor and 
prescribe PrEP, 86% reported that they recorded their prescribing activities through their clinic 
EMR. On a positive note, 71% stated they did not need more training at their clinic. 
The second survey response group was composed of the 30 respondents who indicated 
that they are referring PrEP (Table B2). Different from the first group, approximately three-
quarters (73%) of the responses came from registered nurses. Thirteen clinics (43%) had a nurse 
practitioner on-site at least four hours a week and eleven (37%) had a physician. Again, in 
contrast to the first group, only 43% of clinics offered family planning services and 33% offered 
insurance navigation, suggesting that the other services were not provided at all. Out of 30 
responses, those who were billing for services revealed that nine clinics billed for STD services 
and seven clinics for family planning. One-third of the respondents in the second group stated 
that they had referred 1 to 9 individuals for PrEP and less than a quarter of the respondents stated 
they referred over 50. However, 17% did not respond to this question. Analyzing the clinic 
processes for the second group, respondents indicated yes to the following: taking a 
comprehensive sexual history (76%), providing patients with information on PrEP (73%), 
determining if a patient is eligible for PrEP (33%), being aware of the HIV consultation portal 
(43%), and having protocols in place for linking patients to support services (57%). Of the 
clinics who stated they were knowledgeable about services that pay for PrEP, 27% knew about 
Healthy Michigan, 57% knew of Medicaid, 40% knew of GILEAD, and 37% knew of private 
insurers. 




Clinic capacity – a critical component to prescribing PrEP – was evidenced in the second 
group as follows: 21 (70%) of the respondents disclosed that they could test every three months 
for HIV, 23 (77%) could perform STD screening, 15 (57%) screened for hepatitis, 21 (70%) can 
do pregnancy tests, 9 (30%) could do a urinalysis, and 6 (20%) could monitor creatinine levels. 
The main source for monitoring PrEP for the second group was utilization of Evaluation Web (a 
surveillance system that collects data on HIV; 40%), and most did not have a way to record their 
referrals (30%). PrEP referrals were mostly being made to private physicians (40%) and HIV 
clinics (33%). Similar to group one, the training and education about PrEP was done through 
training events with or without continuing education credits (73%) and utilizing MDHHS 
resources (60%). 
Unlike the first group, data on strengths and weakness was captured for the second group. 
Strengths of the clinic, when it came to referring PrEP were as follows: the ability to engage in 
conversations about PrEP (57%), the ability to offer educational material (53%), and the ability 
to assist individuals with routine testing (67%). Half of the LHDs referring PrEP reported their 
main concern to be that their clinic does not have enough staff and concerns with billing and 
reimbursement. For future implementation, only 17% stated they would like to begin prescribing 
PrEP, 60% wanted to create more education and training opportunities for staff, and 50% of 
participants would like to either create their own educational materials or engage in community 
outreach. Finally, the second group reported the need for more tools and resources such as 
education for staff members about PrEP (67%), more cost and payment options (57%), more 
monitoring and evaluating of PrEP efficacy (36%), more educational materials for patients 
(57%), more protocols and examples from other clinics (53%), and more guidance from the state 




health department (47%). Ten (33%) participants expressed that it would be unlikely to prescribe 
PrEP in their clinic.           
 The final group of 22 survey respondents reported that they were not doing any activities 
around PrEP, thus making them an ideal population to focus on in the future. Out of the 22 
respondents, 17 of them were registered nurses and 2 were medical directors. When asked if 
clinics had a nurse practitioner, physician assistant, or physician on-site at least four hours per 
week, 41% reported having a nurse practitioner, while 32% reported having a physician. The 
most common services offered among those in the third group were, family planning (77%), 
insurance navigation (27%), and other services specified by the respondent (27%). For services 
that were billed at these clinics, 77% were STD services, 73% family planning, and 20% of 
clinics were not billing at all. For LHDs clinic processes, those who responded yes to the 
question indicated 68% were taking a comprehensive sexual history, 77% knew where to get 
PrEP information, 23% provided patients with information about PrEP, and 86% indicated they 
had protocols for linking patients to support services. On the contrary, 77% said their clinic does 
not have a way of determining if a patient is eligible for PrEP and 41% do not know where to 
refer individuals. Sixty-eight percent of clinics offered HIV testing every three months, 82% 
offered STD screening, 40% screened for all hepatitis, 77% offered pregnancy tests, and 36% 
could perform urinalysis. However, 63% of LHDs could not perform testing for creatinine. 
When LHDs were asked about their main concern for referring or prescribing PrEP, 
clinic responses were that they do not have enough staff (50%), there is a lack of awareness and 
knowledge among the department (27%), PrEP is not in demand in their clinic (41%), there are 
difficulties with laboratory monitoring (36%), and there are concerns about billing and 
reimbursement (45%). When asked about their ability to increase activities for PrEP in the future 




and what activities they would include, 55% of the participants indicated community education 
and outreach, 32% stated to create flyers and pamphlets for the clinic, 41% said healthcare 
provider education and outreach, 32% mentioned training events for staff, 18% mentioned 
prescribing PrEP, and 41% would collaborate with healthcare providers to support PrEP up- 
take.  
Additionally, when asked about preferred methods for employee trainings, a majority of 
the respondents expressed interest in in-person trainings with or without CMEs/ CEUs (63%), 
collaboration with other departments (50%), educational webinars (73%), and utilization of 
MDHHS resources (73%). Overall, 32% of the third group reported that they want to implement 
a PrEP intervention, 46% would like to engage in more community outreach and education, 50% 
said they would like to develop educational materials for patients and staff, and 18% mentioned a 
desire to monitor and evaluate PrEP. Respondents from this group reported that it would be 
beneficial to have more of the following: educational materials to share with patients (73%), 
protocols for PrEP implementation (59%), examples of PrEP implementation from other clinics 
(59%), tools to assess community interest (36%), resources to assess individual risks (64%), 
information on billing (55%), guidance from the state health department (46%), and guidance on 
monitoring PrEP (45%). Forty-one percent of the clinics in response group three had expressed it 
was unlikely to implement PrEP in the future, 77% were undecided, and 10% would attempt to 
implement PrEP in the next six months to two years.       
 Lastly, the only open-ended data from the survey varied from each clinic but included 
valuable feedback. From the 58 responses, 24 participants provided statements about what they 
feel MDHHS could help with PrEP implementation. The first group had five responses, the 




second had thirteen, and the third had six responses. See Appendix C for direct quotes from 
LHDs.  
Discussion and Limitations 
Since this is the first assessment tool used in Michigan looking at LHDs and their 
activities around PrEP, it should be considered baseline data. From the data gathered in the 
survey, we were confident that we could understand what LHDs are doing with PrEP and how 
MDHHS might be able to assist them with future implementation. For those in the first response 
group (i.e., those who are prescribing PrEP), evidence showed that most clinics will continue to 
support PrEP initiatives and are willing to support other clinics with PrEP implementation. 
Unfortunately, we were not able to learn from their strengths and weakness due an error of 
missing questions in the survey. The second group was comprised of those either undecided or 
not likely to prescribe PrEP in the future but were more interested in education and training for 
staff and patients. Although, the second group’s main concerns were that their clinic does not 
have adequate staff necessary to keep track of billing and reimbursement for PrEP. Group three 
was undecided or not likely to implement PrEP in the future, but were open to receiving all tools 
and resources to gain more information about PrEP, especially for patients and staff. For those 
specific LHDs who may not be implementing or expanding any PrEP activities in the near future, 
we can suggest that MDHHS can increase distribution of education, tools, and resources about 
PrEP.  
Additionally, comparing groups one and two, the first variation between the groups was 
the background on the clinics. In the first group, almost every service offered to patients and 
services billed in the clinic was selected by participants. The second group indicated very little 
services offered, did not bill for HIV services, and only billed for a few STD services. The last 




group only billed for STD services and family planning services. Groups 2 and 3 did not have 
providers on-site at least four hours a week as frequently as Group 1. Different dynamics 
between the clinics could be a reason why only seven clinics are prescribing PrEP. Likewise, 
some implications for the STD program would be to first start with determining which clinics 
have a provider on-site at least four hours a week. Only responses from groups one and two 
revealed that they had either a nurse practitioner or physician on-site at least four hours a week. 
This may not be a barrier to prescribing or referring PrEP in those clinics. However, those who 
are not doing any activities around PrEP cannot be prescribing without a prescription from a 
nurse practitioner, physician assistant, or physician.  
Continuing with the background of the clinic, the first group of clinic processes included 
determining if an individual is eligible for PrEP. According to the responses, all participants in 
this group were successful in completing this task. It is worthy to mention that this is one of the 
first steps to PrEP implementation. In order to prescribe PrEP, clinics must know which 
populations are at-risk for acquiring HIV and how to effectively communicate that throughout 
the clinic. The clinics in the first group can set examples for others to assist with PrEP 
implantation. Considering the clinical processes for group three, 77% of individuals who 
responded to the survey did not have a process for determining if a clinic was eligible and 41% 
did not know where to refer individuals for PrEP.  
This draws attention to these clinics implying that they need helping finding at-risk 
patients before they can move any further with implementing PrEP. This could come from the 
STD program by directing those clinics to the MDHHS website, which houses the PrEP Toolkit. 
Another solution could be to have the STD epidemiologist develop a specific criteria list for 
clinics to recruit eligible patients. Following clinic processes, the next step would be to assess 




participants’ lab capacities. Determining lab capacity for clinics is vital to the process of 
enrolling individuals on PrEP. 
The lab capacity question on the survey thoroughly displays what test must be done 
before prescribing PrEP and whether they have the ability to do so. An obstacle for most clinics 
is the creatinine clearance. Between the second and third groups, over fifty percent of clinics do 
not have the capacity to screen individuals for their liver function. This is one of the prerequisites 
for an individual to be prescribed PrEP. Also, GILEAD (2016), the creator of Truvada, indicates 
side effects of PrEP that can cause damage to the liver over time, so it is necessary to run this 
test. Therefore, more follow-up should be led by the STD program for those LHDs that cannot 
perform this laboratory requirement. The same follows for the other lab capacity functions. 
Although, having the inability to conduct creatinine screening had the most number of responses, 
we cannot rule out these clinics for future prescribing. MDHHS has reached out and engaged in 
conversations with the state laboratory and CDC to find a viable option in determining if clinics 
could increase creatinine screening at a low-cost to patients in the future.     
Aside from clinic processes and laboratory capacity, other attributes in a clinic play a role 
in PrEP implementation. For instance, 85% of the first group was successful at creating 
relationships with providers and community partners. Also, group two indicated that, for future 
expansion with PrEP they would like to do outreach, education, and collaboration with 
healthcare providers. As for group three, if they were to start implementing PrEP, over half 
(55%) stated they would like to do community outreach and education and 41% would want 
healthcare and provider education and outreach. 
For those only referring and not doing any activities around PrEP, this feedback can be a 
sign that, although they may not be able to currently participate in PrEP activities, MDHHS 




could create a position, like a liaison. This position would specifically work with PrEP and assist 
with collaboration between the health department and other providers. The position would have 
an array of duties, ranging from helping with provider outreach and education, connecting 
patients to providers for PrEP referrals, or assisting patients with follow-up appointments. 
Another valuable question from the survey offered to the second and third groups asked about 
what resources or tools would assist them with future PrEP implementation. This question had 
quite high proportions of responses, which should be considered significant feedback for 
MDHHS. 
It is key to take what we learned from the survey and apply new interventions to clinics, 
even if they are already prescribing PrEP. For example, questions about the need for educational 
materials to share with patients, protocols, resources to assess an individuals’ risk, examples 
from other clinics, and more information on billing was indicated by more than fifty-percent of 
responses. All of these areas could be covered in a protocol developed by the STD program. A 
protocol along with educational sessions about PrEP implementation would benefit LHDs 
because they do not have any previous data or interventions to replicate. Thus, the state STD 
program can play a vital role in creating resources for the LHDs to learn and expand PrEP 
implementation.    
Finally, open-ended evidence can be of use to MDHHS by helping focus on clinics that 
need the most assistance with PrEP implementation. The feedback from those who are 
prescribing was considerably helpful so that those clinics can take next steps for PrEP expansion. 
Specifically, participant responses to the open-ended questions voiced the need of assistance in 
developing a tracking tool within EHR to notify patients when due for next PrEP visit, and to 
incorporate PrEP prescriptions in STD/HIV incidence reporting to help identify trends, to name a 




few. Currently the state STD program is creating new fields in their STD reportable condition 
form so that this information can be documented. Respondents also mentioned the desire to 
provide pre-written policies and procedures for LHDs and provide more marketing materials – 
paper and video – to participants. This suggests that although this particular clinic has prescribed 
PrEP to individuals, perhaps having a protocol created by the state STD program would be 
beneficial to future clinics who would like to start prescribing. The state STD program can 
inquire with this clinic to develop procedures and protocols. This specific statement was made 
throughout the survey from respondents in all three groups, suggesting it could be a useful tool 
all around – even for those who would like to refer PrEP. 
The second group of the study provided the most feedback, stating that the barriers to 
PrEP implementation revolved around funding, staffing, and a lack of education. The funding 
side of the spectrum goes in hand with the staffing side, and may not be fixed at this time, 
especially with a nationwide budget cut to all local health departments. However, because so 
many LHDs indicated that some of their staff and clients need more education on PrEP, this is a 
job the program can handle. There are pamphlets and flyers that are currently being distributed to 
LHDs. After the survey was completed, the goal is to have the STD program create resources, 
webinars, and protocols for clinics to use if they wish to implement PrEP. Overall, clinics feel 
they do not have the tools or resource to get started, which suggests a need for more outreach 
from the state health department in these areas. Again, comments were made about education 
among all groups. This should be the first step when thinking about how to shape the way PrEP 
will be implemented in clinics, starting with education.   
This study had several limitations. First, three questions were missing from the survey for 
the first response group. These questions focused on concerns, strengths, and weaknesses for 




those who were prescribing PrEP and would have been particularly important to future 
implementation in clinics who are not prescribing PrEP. Perhaps there should have been a pilot 
test for a select few individuals to identify errors or challenges when completing the assessment. 
Additionally, there are some questions that did not require a response, which meant valuable data 
could have been missing if it was not filled in. In the future, this will be required in order to gain 
a better understanding of exact activities around PrEP. 
Another big limitation to this study was the inconsistency of questions between all three 
groups. There were some questions that were addressed in all surveys and then there were some 
questions only presented in one or two of the groups. Comparably, the survey was sent to 45 
LHDs, but there were a few occasions where there was more than one respondent from a LHD. 
From those who did have more than one respondent from the same LHD, there was a variation of 
responses from each individual. Meaning, within the same clinic, one response stated they were 
prescribing PrEP and other stated they were not. Although, there was no over-lapping with the 
data, it was still analyzed by number of responses, not by number of health departments. Also, 
selecting a convenience sampling technique yielded some disadvantages, such as under-
representation of the sample because multiple sites were invited to the survey from the same 
LHD. This caused a variation of responses from the same LHD but individuals that may be at a 
different clinic location than the first.  
Moreover, there was a possibility there were too many groups in this study that made the 
data difficult to analyze. From an analysis view-point, further trial and error could have been 
explored before sending the survey. Analysis was complicated due to the fact that there were 
multiple responses to questions, there were three response groups to the study, and not every 
group was offered the same questions. Therefore, the qualitative analysis had to be conducted 




without the use of a statistical software system. Since this was a baseline study, future review 
and modification of this survey should be evaluated to capture the expansion of PrEP 
implementation in LHDs across Michigan.    





1. The current project is an example of an evidence-based approached to public health. 
Throughout the process of developing, distributing, and analyzing a survey, it was crucial to 
apply epidemiological methods, and to utilize qualitative and quantitative analyses to 
interpret the results of the survey. Before the survey was created, a thorough review of the 
literature was conducted, which provided insight into the types of populations that are 
targeted in interventions to reduce rates of HIV. After research on the public health 
significance of this topic, further analysis of previously implemented surveys was conducted 
to determine the nature of the survey. The PrEP LHD survey was then created using a 
convenience sampling type method, which was decided due to the previous research 
supporting the increased strength of a survey using these types of questions. The results for 
this project were baseline and specifically intended for the use of the STD/ HIV program. 
Additionally, MDHHS will distribute similar surveys in the future for evaluation of LHDs 
and PrEP. After the results were interpreted, a presentation was created and shown to the 
STD management team at MDHHS. With the success of this survey and the very small 
number of states that have conducted a survey around this topic, we plan to develop a 
manuscript based on the current study to be published in a peer-reviewed journal. 
 
2. This project also incorporated planning and management to promote health. Before any 
survey is created, a community assessment is necessary to determine if there is a need for an 
intervention. From scholarly research articles and reviewing Michigan data on HIV, it was 
evident that there has been an increase in HIV rates, especially among young Black MSM. 
Since a biomedical intervention was developed almost five years ago, it was important to 
introduce PrEP to this population. However, research has shown that this is not a typical 
habit for individuals at-risk for HIV to encounter. After understanding the public health 
problem, it is even more important to determine capacity in clinics to see if it is viable to 
implement this type of intervention. This survey was developed as an assessment tool for 
MDHHS to learn from LHDs how the design of a program or intervention may be created 
and implemented. For MDHHS, this baseline data can increase awareness around PrEP in 
LHDs and create new interventions to help reduce rates of HIV. In the future, MDHHS will 
be able to refer to this study and re-revaluate public health programs that were implemented 
as a result of this survey. It is also worthy to note that principles and tools of a budget and 
resource management was established throughout the PrEP LHD survey. Of the 57 
respondents, 23 of them stated their main concern for implementing PrEP was the lack of 
staffing and funding. Unfortunately, resource allocation and the ability to pay for the 
screening requirements for PrEP can cost a lot of money that clinics do not have. 
Specifically, with the new administration, most STD and HIV programs in the United States 
have either lost funding or will in the future. According to the President’s proposed budget 
for 2017, the CDC HIV/AIDS, Viral Hepatitis, STD, and TB program had a 5 million dollar 
reduction in funding as whole, with that 5 million dollar loss coming solely from STD 
prevention money. Budget and resource management was a small part of the survey but it is 
continuously discussed and highly acknowledged at the state level. 




3. After completing my internship, I feel as though this project demonstrates my competence in 
my knowledge of public health and health care systems. Although, the assessment was not 
dealing with international settings, I was able to work within state and national systems. The 
literature I reviewed on national systems helped identify the questions and type of survey that 
would be created. Reviewing research from different countries also helped preface the 
purpose of the survey. From an organizational level, it was very evident from the survey that 
some clinics were not all on the same page when it came to PrEP activities in their clinic, 
especially compared to the state level health department. Although most health department 
employees at the state-level reportedly knew about PrEP and expressed a desire to create 
interventions to increase its usage, fewer people at the local-level share this same knowledge. 
These results were shocking because while working on my capstone project within the state 
health department, as well as working during my master’s degree, you learn that one of the 
main goals for public health is reducing disparities and health equity. However, if certain 
people are in disagreement or have different viewpoints about a topic throughout the clinic, 
like PrEP, then those factors increase. Hopefully, this was not a direct affect to individuals 
but it is critical to be organized structurally in order to have successful outcomes. If there is 
no internal organization then how will clinics have successful outcomes for their patients? I 
am assuming it would be very difficult. On a lighter note, this data was brought to the 
program so they can learn more from the local health sector and help tackle challenges not 
only pertaining to PrEP but to every public health problem. 
Additionally, during my internship I replicated and modified a national and statewide 
program (Data to Care) to fit the project I was creating, Data to PrEP. I had to engage in 
numerous conversations locally and review research from the national program in order to 
figure out how my program was going to operate. It was easy to figure out who to talk to 
once I received an organizational chart. Visually seeing how the STD program was 
categorized, helped me find who the right person was to talk to about my program. Moving 
toward the Detroit Health Department, they were currently implementing the national 
program so that was my first contact. I obtained a lot of information at the local level such as, 
protocols, flow- charts, and recruitment scripts for the program. I then was able to transfer 
those resources to my proposed program. The logic around the program was that surveillance 
data could be utilized based on a specific criteria to find eligible candidates for PrEP. I then 
had to establish the criteria by communicating with multiple levels and work with the state 
and national databases to determine my priority population for the program. This included 
using Michigan’s Disease Surveillance System (MDSS) to find eligible candidates for PrEP 
and the national HIV registry (Enhanced HIV Surveillance System, eHARS) to determine if 
those candidates HIV status. This process was done using a software system called, LinkPlus, 
which allowed me to take two files and link them together by selecting a few variables that 
will match individuals who may have an STD and HIV infection, or not. Above all, it was an 
experience working with multiple levels of public health and different registries that hold 
valuable patient information. There were a lot of trial and errors working with both systems 
due to the fact that this was my first time using them. Most systems I utilize operate 
differently and they each have their own flaws. That was a big learning curve throughout this 
process, it also made me realize that there are too many systems with all the same 




information. This led me to believe we should have an integrated system, specifically 
between HIV and STDs, whether that be national or locally. Since information is present in 
multiple systems throughout Michigan, it would be beneficial for not only the state but for 
our patients, that information be housed in one system. I believe an integrated system could 
reduce disparities in health. For example, an integrated system can help achieve health equity 
by having access to multiple records for an individual. If field workers follow up with 
someone who has a positive gonorrhea or chlamydia test, that worker is going to want to 
know if they are HIV positive so that they can have their partners tested for chlamydia or 
gonorrhea and especially HIV. An integrated system can also help at an organizational level. 
In the STD and HIV program, there are staff who follow-up on only syphilis cases and then 
there are staff who follow-up on only HIV cases. Often times, an individual is newly co-
diagnosed with both syphilis and HIV, therefore two different staff members are following-
up with this person, twice. They are having the same interview with this patient. That can 
drive the patient away stating that they have already be interviewed, and after news like that 
they do not want to be interviewed again reducing the chances of them coming back for 
follow-up appointments or securing partners. Therefore, integrating systems and departments 
would most definitely reduce the public health impact on an individual and community. It 
think it is vital to have organization and integration in order to have successful patient 
outcomes.       
4. Finally, the fourth most fitting competency for my MPH, concentration in health education, 
is applying data collection methods to assess a community’s needs, assets, and capacity. The 
PrEP LHD survey was projected to fulfill that competency and more. Clinics, who know 
their patients best, were able to identify what types of populations they were meeting. When 
creating this survey, I did not know much about LHDs and their relationships with their 
clients. Before thinking about the survey, my first step was to research the topic and 
determine the real reason to assess LHDs and their status around PrEP. This was 
accomplished by reviewing surveys conducted by nationally publicized scholarly articles and 
other various state surveys. This helped identify what type of audience would be receiving 
the survey, the layout, and how questions would be illustrated. Questions developed on the 
survey were developed according to previously implemented surveys, with similar questions 
to the LHD PrEP survey. As a result of the presentation to the management team continuous 
monthly meetings called, PrEP Internal Workgroup, were created. These meetings 
incorporated discussion about current PrEP activities, workshops, or conversations that are 
being held at the state level but then returned to the local level. The workgroups are very 
productive in creating ways to increase PrEP implementation throughout the state. Brian-
storming about how to plan for a prevention program, such as PrEP, is continuously 
discussed as MDHHS strives to increase awareness in every LHD. In the future, the STD 
program will utilize this survey to follow-up with LHDs and re-evaluate PrEP activities.    
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Questions and responses from LHDs prescribing PrEP (Survey Response Group 1) in Michigan, 
2017  
Question Response Count % 
Do you offer any PrEP 
related services in your 
clinic? We are prescribing PrEP 7   
What is your profession?     
  Social Worker - no. (%) 1 14% 
  Registered Nurse 0 0% 
  Nurse Practitioner 3 43% 
  Physician Assistant 0 0% 
  Physician 1 14% 
  Medical Director 0 0% 
  Other (please specify) 2 29% 
Does your clinic have any 
of the following providers 
on-site at least four hours 
per week?       
 Nurse Practitioner 6 86% 
 Physician Assistant 0 0% 
 Physician 1 14% 
 None of the above 0 0% 
What services does your 
clinic offer?       
 Primary Care 3 43% 
 Family Planning 4 57% 
 Mental Health Services 2 29% 
 Medication Adherence Support 2 29% 
 Insurance Navigation 5 71% 
 Transportation Assistance 2 29% 
 Substance Abuse Treatment 0 0% 
 Other (please specify) 2 29% 
  




Table B1, continued  
What services does your 
clinic bill for?       
 HIV Services 3 43% 
 STD Services 6 86% 
 Hepatitis Services 2 29% 
 Partner Services 0 0% 
 Prevention Case Management 0 0% 
 Adherence Counseling 0 0% 
 Family Planning Services 3 43% 
 We are not billing 0 0% 
 Other (please specify) 1 14% 
Approximately, how many 
individuals have you 
prescribed PrEP in the last 
year?       
 1 to 9 1 14% 
 10 to 24 3 43% 
 25 to 50 1 14% 
 Over 50 1 14% 
 No response 1 14% 
Do you feel your clinic 
needs more training on 
PrEP?       
 Yes 2 29% 
 No 5 71% 
Thinking about your clinic 
processes please respond 
to the questions below. For those who answered yes only:   
 
For all incoming patients, does your clinic take a 
comprehensive sexual history? 7 100% 
 
Does your clinic have a process for determining if a 
client is eligible for PrEP? 7 100% 
 
Are your front desk staff aware that PrEP is being 
offered in your clinic? 6 86% 
 
If a patient asks about PrEP, is your front desk staff able 
to triage calls and visits appropriately? 6 86% 
 
Does your clinic know about the Michigan HIV 
Consultation Portal? 
 6 86% 
 
Do you have protocols for linking patients to support 
services (mental health, transportation, substance 
abuse treatment, etc.)? 6 86% 




Table B1, continued 
Are you aware of programs 
that help pay for PrEP?       
 Healthy Michigan 5 71% 
 Medicaid 6 86% 
 GILEAD 7 100% 
 Patient Advocate Foundation 2 29% 
 Patient Access Network Foundation 2 29% 
 Private Insurance 6 86% 
 I am not aware of any 0 0% 
Which of the following 
influenced your clinic's 
decision to begin 
prescribing PrEP?       
 Patient's increase interest in PrEP 5 71% 
 
The increase of discussion about PrEP at conferences 
and trainings 3 43% 
 Support and encouragement from other clinics 0 0% 
 State health department support 1 14% 
 Community outreach 2 29% 
 Other (please specify) 2 29% 
How does your clinic 
monitor the number of 
individuals being prescribed 
PrEP?       
 Michigan Disease Surveillance System (MDSS) 0 0% 
 Evaluation Web 0 0% 
 Partner Service Web 0 0% 
 Our clinic EMR 6 86% 
 
We do not have a way of collecting information on 
PrEP 0 0% 
 Other (please specify) 1 14% 
  




Table B1, continued 
What additional PrEP 
activities is your clinic 
implementing?       
 Community education and outreach 5 71% 
 
Building relationships with providers and community 
organizations 6 86% 
 
Creating images and informational flyers/ pamphlets 
for the clinic 3 43% 
 Holding training events for staff 2 29% 
 Connecting patients with support services 5 71% 
 Other (please specify) 0 0% 
How is your clinic educating 
and training employee’s 
about PrEP?       
 Electronic letters/ bulletins with health information 0 0% 
 Holding in-person training events with CME's/ CEU's 2 29% 
 Holding in-person training events without CME's/ CEU's 4 57% 
 Participating in educational webinars 5 71% 
 
Promotion of federal training opportunities (i.e. AIDS 
education and Training Center) 3 43% 
 Utilizing MDHHS resources 4 57% 
 None of the above 0 0% 
 I don't know 0 0% 
 Other (please specify) 3 43% 
What are your clinics 
strengths when it comes to 
prescribing or referring 
PrEP?       
 Engaging in conversations regarding PrEP 0 0% 
 Offering educational materials on PrEP 0 0% 
 Connecting patients to support services 0 0% 
 
Talking to partners of persons living with HIV about 
PrEP 0 0% 
 
Assisting individuals with follow- up appointments for 
PrEP 0 0% 
 Helping maintain adherence for PrEP 0 0% 
 Other (please specify) 0 0% 
  




Table B1, continued 
What challenges has your 
clinic faced when 
incorporating PrEP as an 
intervention?       
 
Lack of PrEP awareness and knowledge among 
department staff 0 0% 
 
The length of time that it takes for additional testing 
and counseling 0 0% 
 Lack of staffing in your facility to support PrEP 0 0% 
 Difficulties with laboratory testing and monitoring 0 0% 
 Financial access to PrEP for patients 0 0% 
 Concern about reimbursement from third-party payers 0 0% 
 Our clinic did not face any challenges 0 0% 
What is the main concern 
for prescribing PrEP?       
 Our clinic does not have adequate staff 0 0% 
 PrEP is not in demand at our clinic 0 0% 
 Billing and reimbursement 0 0% 
 Lack of support from upper management 0 0% 
 N/A we do not have concerns at this time 0 0% 
 Other (please specify) 0 0% 
What are your clinic's 
future goals for ensuring 
PrEP is a sustainable 
intervention?       
 Continue to support PrEP with current activities 6 86% 
 Engage in more community education and outreach 3 43% 
 
Develop partnerships with other clinics and 
organizations 1 14% 
 
Create more training and education opportunities for 
staff 3 43% 
 
Develop a survey for patients to assess PrEP knowledge 
and usage 0 0% 
 Apply for grants to fund more PrEP activities 1 14% 
 Monitor and evaluate PrEP uptake and impact 7 100% 
 
Create new positions in our clinic to assist with PrEP 
implementation (i.e. PrEP Navigator or Nurse 
Practitioner) 1 14% 
 Other (please specify) 0 0% 
  




Table B1, continued 
How does your clinic plan to 
expand PrEP activities?       
 Create trainings and educational sessions 2 29% 
 Develop educational materials for our patients 1 14% 
 
Assist and offer support to other clinics who want 
to begin prescribing PrEP 5 71% 
 
Develop a survey for patients to assess PrEP knowledge 
and usage 1 14% 
 Evaluate and monitor PrEP uptake and impact 4 57% 
 Other (please specify) 1 14% 
 
Table B2 
Questions and responses from LHDs prescribing PrEP (Survey Response Group 2) in Michigan, 
2017  
Question Response Number % 
Do you offer any PrEP related services in your 
clinic? 
We are referring individuals to 
other clinics for PrEP 30 1 
What is your profession?     
  Social Worker  0 0% 
  Registered Nurse 22 73% 
  Nurse Practitioner 4 13% 
  Physician Assistant 0 0% 
  Physician 0 0% 
  Medical Director 0 0% 
  Other (please specify) 4 13% 
Does your clinic have any of the following 
providers on-site at least four hours per 
week?       
 Nurse Practitioner 13 43% 
 Physician Assistant 1 3% 
 Physician 11 37% 
 None of the above 12 40% 
  




Table B2, continued  
What services does your clinic 
offer?       
 Primary Care 1 3% 
 Family Planning 13 43% 
 Mental Health Services 0 0% 
 Medication Adherence Support 1 3% 
 Insurance Navigation 10 33% 
 Transportation Assistance 2 7% 
 Substance Abuse Treatment 0 0% 
 Other (please specify) 21 70% 
What services does your clinic 
bill for?       
 HIV Services 0 0% 
 STD Services 9 30% 
 Hepatitis Services 2 7% 
 Partner Services 1 3% 
 Prevention Case Management 0 0% 
 Adherence Counseling 0 0% 
 Family Planning Services 7 23% 
 We are not billing 6 20% 
 Other (please specify) 9 30% 
Approximately how many 
individuals have you referred 
PrEP to in the last year?       
 1 to 9 10 33% 
 10 to 24 1 3% 
 25 to 50 0 0% 
 Over 50 3 10% 
 No response 5 17% 
Thinking about your clinical 
processes please respond to 
the questions below. (yes only responses)     
 
For all incoming patients, does your clinic take a 
comprehensive sexual history? 23 77% 
 
Does your clinic provide patients with information 
about PrEP? 22 73% 
 
Does your clinic have a process for determining if a 
client is eligible PrEP? 10 33% 
 
Does your clinic know about the Michigan HIV 
Consultation Portal? 13 43% 
 
Do you have protocols for linking patients to support 
services (mental health, transportation, substance 
abuse treatment, etc.)? 17 57% 




Table B2, continued  
Are you aware of programs that help pay for 
PrEP?       
 Healthy Michigan 8 27% 
 Medicaid 17 57% 
 
GILEAD medication assistance program and 
coupon card 12 40% 
 Patient Advocate Foundation 0 0% 
 Patient Access Network Foundation 2 7% 
 Private Insurance 11 37% 
 I am not aware of any 7 23% 
Does your clinic have the ability to offer 
laboratory testing for: (yes only responses)     
 HIV testing every 3 months 21 70% 
 
Monitor creatinine clearance every 3-6 
months 6 20% 
 STD screening 23 77% 
 Screening for all hepatitis 17 57% 
 Pregnancy tests 21 70% 
 Urinalysis 9 30% 
How does your clinic monitor the number of 
individuals you refer for PrEP?       
 
Michigan Disease Surveillance System 
(MDSS) 0 0% 
 Evaluation Web 12 40% 
 Partner Services Web 2 7% 
 Our clinic EMR 6 20% 
 
We do not have a way of collecting 
information on PrEP 9 30% 
 Other (please specify) 3 10% 
Where are you making PrEP referrals?       
 Private Physicians 12 40% 
 HMOs 0 0% 
 HIV Clinics 10 33% 
 Don't know 0 0% 
 Other (please specify) 8 27% 
  




Table B2, continued 
How is your clinic educating and 
training employees about PrEP?       
 Electronic letters/ bulletins with health information 9 30% 
 
Holding in person training events with CME's/ 
CEU's 15 50% 
 
Holding in person training events without CME's/ 
CEU's 7 23% 
 Participating in educational webinars 20 67% 
 
Promotion of federal training opportunities (i.e. 
AIDS Education and Training Center) 13 43% 
 Utilize MDHHS resources 18 60% 
 Other (please specify) 1 3% 
What are your clinics strengths 
when it comes to referring PrEP?       
 Engaging in conversations regarding PrEP 17 57% 
 Offering educational materials on PrEP 16 53% 
 Connecting patients with support services 12 40% 
 
Talking to partners of persons living with HIV about 
PrEP 10 33% 
 Assisting individuals with routine HIV testing 20 67% 
 Building relationships with other providers 10 33% 
 Other (please specify) 2 7% 
What is the main concern that 
prevents you from prescribing 
PrEP?       
 Our clinic does not have adequate staff 14 47% 
 PrEP is not in demand at our clinic 20 67% 
 Lack of support from upper management 5 17% 
 Concerns about billing and reimbursement 13 43% 
 Other (please specify) 5 17% 
What would your clinic do to 
expand PrEP activities?       
 Begin prescribing PrEP 5 17% 
 
Engage in more community education and 
outreach 15 50% 
 
Create more training and education opportunities 
for staff 18 60% 
 
Develop educational materials for our patients and 
staff 15 50% 
 Monitor and evaluate PrEP uptake and impact 9 30% 
 Assign staff to oversee PrEP activities 9 30% 
 Apply for grants to fund more PrEP activities 8 27% 
 Other (please specify) 4 13% 




Table B2, continued  
What areas of PrEP does your clinic 
need more information about?       
 
Identifying populations and individuals that are at 
high-risk 8 27% 
 Educating patients about PrEP 11 37% 
 Educating staff members about PrEP 20 67% 
 Patient assistance for support services 12 40% 
 Cost and payment options for prescribing PrEP 17 57% 
 Clinical reimbursement for providing services 13 43% 
 
Establishing a protocol for referring and 
prescribing 12 40% 
 Monitoring and evaluating PrEP 22 73% 
 Increasing testing and preventative services 7 23% 
 Other (please specify) 2 7% 
What tools or resources could be 
helpful for implementing PrEP in your 
clinic?       
 
Educational materials about PrEP to share with 
patients 17 57% 
 Protocols for prescribing and delivering PrEP 16 53% 
 
Examples of other clinics that have implemented 
PrEP 16 53% 
 
Tools/ surveys to assess community interest and 
knowledge on PrEP 11 37% 
 
Resources to assess an individual’s risk or who 
would benefit from PrEP 13 43% 
 More information on billing for PrEP 15 50% 
 
Guidance and direction from the state health 
department on how to expand PrEP 14 47% 
 Guidance or information on monitoring PrEP 12 40% 
 Other (please specify) 1 3% 
Ideally, when would you like to start 
prescribing PrEP?       
 As soon as possible 1 3% 
 Over the next 1 to 2 years 4 13% 
 Undecided 7 23% 
 
It is unlikely that our clinic will start prescribing 










Questions and responses from LHDs not doing any activities around PrEP (Survey Response 
Group 3) in Michigan, 2017  
Question Responses Number % 
Do you offer any PrEP 
related services in your 
clinic? 
We are interested in PrEP but do not know where to 
start OR We know about PrEP but are not doing any 
activities around PrEP OR We do not know much 
about PrEP and are not doing any activities around 
PrEP 22 1 
What is your profession?     
  Social Worker  0 0% 
  Registered Nurse 17 77% 
  Nurse Practitioner 0 0% 
  Physician Assistant 0 0% 
  Physician 0 0% 
  Medical Director 2 9% 
  Other (please specify) 3 14% 
Does your clinic have any 
of the following providers 
on-site at least four hours 
per week?       
 Nurse Practitioner 9 41% 
 Physician Assistant 1 5% 
 Physician 7 32% 
 None of the above 7 32% 
What services does your 
clinic offer?       
 Primary Care 1 5% 
 Family Planning 17 77% 
 Mental Health Services 2 9% 
 Medication Adherence Support 1 5% 
 Insurance Navigation 6 27% 
 Transportation Assistance 1 5% 
 Substance Abuse Treatment 0 0% 
 Other (please specify) 6 27% 
  




Table B3, continued  
What services does your 
clinic bill for?       
 HIV Services 2 9% 
 STD Services 17 77% 
 Hepatitis Services 0 0% 
 Partner Services 1 5% 
 Prevention Case Management 0 0% 
 Adherence Counseling 0 0% 
 Family Planning Services 16 73% 
 We are not billing 6 27% 
 Other (please specify) 3 14% 
Thinking about your 
clinical processes please 
respond to the questions 
below. (yes responses only) Yes   
 
For all incoming patients, does your clinic take a 
comprehensive sexual history? 15 68% 
 Do you know where to get information about PrEP? 17 77% 
 
Does your clinic provide patients with information 
about PrEP? 7 32% 
 
Does your clinic have a process for determining if a 
client is eligible PrEP? 1 5% 
 
Does your clinic know where to refer individuals for 
PrEP? 10 45% 
 
Does your clinic know about the Michigan HIV 
Consultation Portal? 4 18% 
 
Do you have protocols for linking patients to 
support services (mental health, transportation, 
substance abuse treatment, etc.)? 19 86% 
Does your clinic have the 
ability to offer laboratory 
testing for: (yes responses only) Yes   
 HIV testing every 3 months 15 68% 
 Monitor creatinine clearance every 3-6 months 1 5% 
 STD screening 18 82% 
 Screening for all hepatitis 12 55% 
 Pregnancy tests 17 77% 
 Urinalysis 8 36% 
  




Table B3, continued 
What is the main concern 
that prevents you from 
referring to or prescribing 
PrEP in your clinic?       
 Our clinic does not have adequate staff 11 50% 
 
Lack of awareness and knowledge among 
department staff 6 27% 
 PrEP is not in demand at our clinic 9 41% 
 Difficulties with laboratory testing and monitoring 8 36% 
 Lack of support from upper management 2 9% 
 Concerns about billing and reimbursement 10 45% 
 None of the above 1 5% 
 Other (please specify) 2 9% 
What activities would 
your clinic partake in if 
you were to start 
implementing PrEP?       
 Community education and outreach 12 55% 
 
Create images and information flyers/ pamphlets for 
our clinic 7 32% 
 Healthcare provider education and outreach 9 41% 
 Hold training events for staff 7 32% 
 Offer medication adherence services 3 14% 
 Prescribe PrEP 4 18% 
 
Collaborate with healthcare provider to support 
PrEP delivery 9 41% 
 Other (please specify) 5 23% 
What methods would 
your clinic like for 
employee trainings about 
PrEP?       
 Electronic letters/ bulletins with health information 5 23% 
 Holding in person training events with CME's/ CEU's 11 50% 
 
Holding in person training events without CME's/ 
CEU's 5 23% 
 Participating in educational webinars 16 73% 
 
Collaborate with other departments or 
organizations implementing PrEP 11 50% 
 
Promotion of federal training opportunities (i.e. 
AIDS Education and Training Center) 6 27% 
 Utilize MDHHS resources 16 73% 
 Other (please specify) 0 0% 
  




Table B3, continued 
How would your clinic like 
to implement PrEP 
activities in the future?       
 
Implement a PrEP intervention (i.e. refer or 
prescribe PrEP) 7 32% 
 Engage in more community education and outreach 10 45% 
 
Develop educational materials for our patients and 
staff 11 50% 
 Monitor and evaluate PrEP uptake and impact 4 18% 
 Assign staff to oversee PrEP activities 3 14% 
 Apply for grants to fund more PrEP activities 2 9% 
 None of the above 2 9% 
 Other (please specify) 2 9% 
What tools or resources 
could be helpful for 
implementing PrEP in your 
clinic?       
 
Educational materials about PrEP to share with 
patients 16 73% 
 Protocols for prescribing and delivering PrEP 13 59% 
 
Examples of other clinics that have implemented 
PrEP 13 59% 
 
Tools/ surveys to assess community interest and 
knowledge on PrEP 8 36% 
 
Resources to assess an individual’s risk or who 
would benefit from PrEP 14 64% 
 More information on billing for PrEP 12 55% 
 
Guidance and direction from the state health 
department on how to expand PrEP 10 45% 
 Guidance or information on monitoring PrEP 10 45% 
 Other (please specify) 1 5% 
Ideally, when would you 
like to start prescribing 
PrEP?       
 As soon as possible 0 0% 
 Within the next 6 months 1 5% 
 Over the next 1 to 2 years 1 5% 
 Undecided 17 77% 
 It is unlikely that our clinic will start prescribing PrEP 9 41% 
 
  





Direct quotes from a few LHD who responded to open- ended questions on the PrEP survey.  
Quote C1 
Response group 1 opened-ended responses (5) 
“We need to make PrEP visits faster than visits for active health conditions, so it is more 
convenient for clients. This is an internal process, not requiring MDHHS training” 
“Assistance developing a tracking tool within EHR to notify patient's when due for next 
PrEP visit. Incorporate PrEP prescriptions in STD/HIV incidence reporting to help 
identify trends” 
“Provide pre-written policies and procedures for LHDs and provide more marketing 
materials - paper and video” 
“Funding to offer PrEP clinics, we only have one provider that prescribes PrEP and our 
clinics are full.  We do not have additional resources to cover the costs” 
“More ways of educating staff and clients (the use of an existing survey template or 
training guide for staff)” 
Quote C2 
Response group 2 open-ended responses (13)  
“Increase funding for program and establish relationship with medication manufacturer 
for long-term assistance for clients who need PrEP”  
“I think the largest barrier is going to be reimbursement for staff time and helping 
patients pay for their medication.   Education and training on these issues would be very 
helpful. Thank you for reaching out to us and requesting feedback!”  
“Resources and Education” 
“We do not have plans to set up a clinic” 
“Nothing” 
“Recruit PrEP providers in our area” 
“Funding to cover staff time; Need Medical support and involvement and need more 
awareness to Administrative staff about what prep is and it's importance---(*Aim 
information at Medical Director's; Health Officer's/Directors, and Community Health 
Service Director's as they are the one's that ultimately make the final decision on whether 
the agency has the capacity to look at something like this” 
“Find someone to convince my medical director and health officer that prescribing PrEP 
is a necessary function of the health department” 




“We may open an STI clinic in the near future, and then would revisit PrEP” 
“Obtain the support from Medical Directors and Health Officers so we can implement. 
Provide education to medical physicians, NP's, PA's, Behavioral Health, etc.” 
“We would need to have an NP on staff. Currently lack funding” 
“trainings, trainings, trainings” 
“Offering suggestions and examples of how it would be feasible with our level of 
staffing” 
Quote C3 
Response group 3 open-ended responses (6) 
 “Help with the tools to get started” 
“Continue to provide educational materials for LHD staff for both ourselves and 
community providers and also for clients” 
“Increased assistance to low-morbidity counties regarding HIV education and HIV 
PrEP!” 
“Adequate funding to support community outreach and education, staff training, purchase 
of medication and all other costs associated.  We are a very small jurisdiction and would 
prefer to coordinate with Thomas Judd in Traverse City” 
“Assess whether our volume is high enough to make it feasible” 
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